Health & Fitness
Health and Fitness
Health and Fitness
Tue, January 6, 2009 Monogram Biosciences to Present at the J.P. Morgan 27th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--([ BUSINESS WIRE ])--Monogram Biosciences, Inc. (Nasdaq:MGRM) announced today that William D. Young, Chairman of the Board and Chief Executive Officer, is scheduled to present a corporate overview at the 27th Annual J.P. Morgan Healthcare Conference on Thursday, January 15 at 4:00 p.m. Eastern Time (1:00 p.m. Pacific Time) at the Westin St. Francis Hotel in San Francisco, California.
To access the live audio broadcast or the subsequent archived recording, log on to [ http://www.monogrambio.com ] and go to the investor relations section ("Investors/Media" tab) and click on the "Events & Webcasts" link provided on the sidebar menu on the page.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at [ www.monogrambio.com ].
